Nadia Harhen

General Manager, Simulation & Optimization at SandboxAQ

Nadia Harhen has extensive work experience in regulatory affairs and leadership roles in the healthcare industry. Nadia is currently the General Manager of Simulation & Optimization at SandboxAQ and also serves as the Regulatory Affairs Director & Life Sciences Lead for the company. Prior to that, they worked at Google as the Head of Regulatory & Quality for Health & Wellness, Devices & Services, and as the Global Regulatory Lead for Healthcare.

Nadia also worked at Qfix as a Regulatory Affairs Manager, where they successfully managed regulatory processes. Nadia gained valuable experience at Siemens Healthcare USA as a Sr. Regulatory Clinical Affairs Specialist, where they developed and implemented regulatory strategies for MRI products. Nadia was also responsible for risk assessment and acted as an advisor to the R&D and Marketing teams.

Before that, Nadia held positions at Eogea Incorporated as the Vice President of Business Development and at Cordis as a Regulatory Affairs Associate. Nadia started their career at Ethicon, Inc. as a Scientist.

Overall, Nadia Harhen has a strong background in regulatory affairs and has demonstrated leadership in driving regulatory strategies and managing processes in the healthcare industry.

Nadia Harhen's education history includes a range of degrees and certifications. In 2004, they obtained a Bachelor's degree in Biotechnology and Biochemistry from Rutgers University. Following this, from 2008 to 2010, they attended Columbia University and earned a Master of Arts degree in Biotechnology. In 2022, they completed two programs at MIT xPRO: one in Quantum Algorithms for Cybersecurity, Chemistry, and Optimization, and another in Quantum Computing Fundamentals. In the same year, they enrolled in the Stanford University Graduate School of Business and obtained an Executive Chief Product Officer degree. In 2023, they briefly attended Harvard Medical School and obtained a HMX pro certificate in Clinical and Industrial Drug Development. Additionally, in September 2010, they became a RAPS Member through the Regulatory Affairs Certification Program.

Links

Previous companies

Siemens Healthineers logo
Google logo